Pharmacotherapy in Diabetes Management:
Tracking # 20-1395881
Course overview
1. Differentiate between major types of diabetes (Type 1, Type 2, and gestational) and apply the respective diagnostic criteria. 2. Describe the pharmacodynamics, indications, and adverse effects of insulin therapies and insulin analogs. 3. Examine the mechanisms and clinical utility of oral hypoglycemics, GLP-1 receptor agonists, and other non-insulin pharmacotherapies. 4. Develop patient-centered diabetes treatment strategies tailored to clinical context and patient-specific factors. 5. Strengthen patient education efforts, emphasizing safe medication administration and recognition of hypo- and hyperglycemia.
Subject areas
This course counts toward the state boards and subject areas below.
Arkansas State Board of Nursing
Registered Nurse
District of Columbia Board of Nursing
Registered Nurse
Florida Board of Nursing
Advanced Practice Registered Nurse
Registered Nurse
Kansas State Board of Nursing
Registered Nurse
Michigan Board of Nursing
Registered Nurse
Mississippi Board of Nursing
Registered Nurse
New Hampshire Board of Nursing
Advanced Practice Registered Nurse
Registered Nurse
New Mexico Board of Nursing
Registered Nurse
North Dakota Board of Nursing
Advanced Practice Registered Nurse
Registered Nurse
South Carolina Board of Nursing
Advanced Practice Registered Nurse
Registered Nurse
Tennessee Board of Nursing
Advanced Practice Registered Nurse
Registered Nurse
West Virginia Board of Registered Nurses
Advanced Practice Registered Nurse
Registered Nurse
Wyoming Board of Nursing
Registered Nurse
Disclosure statements
eMedEd ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, eMedEd identifies conflicts of interest with its instructors, planners, content managers, and other individuals who can control an activity's content.
All faculty, planners, and/or content managers have nothing to disclose, nor do they have any vested interests or affiliations.